SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Pulmonology (sarcoidosis) Consultation — Mahalia Jackson
| Patient | Mahalia Jackson |
|---|
| Date of birth | 1973-10-26 |
|---|
| Identifiers | MRN HR-ML035-SYN; SSN (made up) 000-35-4692 |
|---|
| Document date | 2026-02-23 |
|---|
| Author | Kwabena Asante-Miller, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Suspected sarcoidosis in a 52-year-old gospel singer with three months of exertional breathlessness, dry cough, tiredness and chest tightness, bilateral hilar lymphadenopathy with upper-zone reticulonodular opacities on today's chest radiograph, a calcium of 10.8 mg/dL, lymphopenia, and palpitations with first-degree atrioventricular block and frequent ventricular ectopy on ECG. Granulomas were reported at an abdominal operation twelve years ago; no pathology report is available. Please see her within two weeks, obtain tissue, and advise on cardiac evaluation and treatment. [S]
Urgency: Urgent, within two weeks; tissue sampling can be arranged before the visit. [S]
Questions for the consultant:
- Is this sarcoidosis, and what is needed to confirm it and exclude tuberculosis, fungal infection and lymphoma?
- Which other organs should be screened, and how should her high calcium and vitamin D be handled?
- Does she have cardiac sarcoidosis, and what tests should be done, and in what order relative to any treatment?
- Does she need treatment, and with what, including a steroid-sparing agent?
- What is her risk of dangerous heart rhythms, and does she need a defibrillator or pacemaker?
- How should treatment be monitored and its side effects prevented, and how can she keep singing and touring?
History of Present Illness
Ms. Jackson, 52, is seen at the request of Dr. Fontenot two weeks after she presented with three months of exertional breathlessness, dry cough, tiredness and palpitations. A CT of the chest two days later showed symmetric hilar and mediastinal adenopathy with perilymphatic upper-lobe nodules, and I performed EBUS-guided needle aspiration five days ago. She had a hysterectomy at 40, when granulomas were reported in her abdomen; no report survives. She stopped her calcium and vitamin D tablet two weeks ago. She has had one more spell of palpitations while singing; no fainting. She has postponed three weeks of concerts. She has no eye symptoms and no rash. Never smoker; no relevant exposures. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Mahalia Jackson was born in New Orleans on October 26, 1911, the third of six children of a man who was a longshoreman by day, a barber by night and a clergyman on Sunday. Her mother died when she was six, and she was raised by an aunt in a poor but respectable home; she left school in the eighth grade to work as a cook and washerwoman. [D]
- In 1928 she moved to Chicago, worked as a hotel maid and laundress, and joined the Greater Salem Baptist Church, where she became a soloist. She never learned to read music. After her Carnegie Hall debut on October 4, 1950, she began touring abroad in 1952, and toured widely for the rest of her life. [D]
- She was closely associated with the civil rights movement and sang at the March on Washington in 1963 before Dr. Martin Luther King Jr.'s speech. When she moved into an all-white neighborhood on the South Side of Chicago, a bullet was fired through a window of her home. [D]
- Touring the segregated South for as many as 200 dates a year, she and her company had trouble finding safe places to sleep, eat and buy gas, sometimes slept in her car, lived on bags of fruit and drove half the night, and she arrived so exhausted she was almost dizzy when she sang; she insisted on being paid in cash because checks were often refused. [D]
- Before and during her first European tour in 1952 she had difficulty breathing during and after performances and severe abdominal cramping, sang many shows in pain, lost a great deal of weight and finally cancelled the tour. On her return she had a hysterectomy, at which numerous granulomas were found in her abdomen, and she was diagnosed with sarcoidosis. From then on she had occasional bouts of fatigue and shortness of breath that became more frequent as her schedule filled. [D]
7 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Breathlessness on exertion and a dry cough for three months, worse on tour, with tiredness and chest tightness; she can no longer hold long phrases; bilateral hilar lymph node enlargement on today's chest radiograph; granulomas were reported at an abdominal operation twelve years ago, with no pathology report available: sarcoidosis must be confirmed by tissue and other causes excluded | resolved | confirmed |
R06.09 | S — Synthetic presenting problem anchored to the documented breathlessness during performances and the 1952 granulomas. Superseded by the tissue diagnosis at the consultation. |
| Palpitations with two spells of light-headedness while singing; ECG today: sinus rhythm with first-degree atrioventricular block (PR 240 ms) and frequent ventricular ectopic beats: cardiac involvement must be looked for | active | confirmed |
R00.2 | S — Synthetic finding; superseded when cardiac sarcoidosis was diagnosed. |
| Hypercalcemia: calcium 10.8 mg/dL with a high 1,25-dihydroxyvitamin D and a low 25-hydroxyvitamin D, while taking an over-the-counter calcium and vitamin D supplement; creatinine slightly raised | active | confirmed |
E83.52 | S — Synthetic finding; resolved on treatment. |
| Pulmonary sarcoidosis with hilar and mediastinal lymph node involvement (Scadding stage II), confirmed by non-necrotizing granulomas on EBUS-guided lymph node aspiration with negative stains and cultures; mild restriction and reduced diffusing capacity; synthetic modern detail linked to her documented sarcoidosis | active | confirmed |
D86.2 | S — Synthetic histology, stage and lung function; her biographer reports a diagnosis of sarcoidosis after granulomas were found at an operation (D, probable). |
Physical Exam
Vital signs recorded on 2026-02-23; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Well; weight 91.6 kg; blood pressure 126/78, pulse 82 and irregular with ectopic beats; oxygen saturation 95 percent on room air |
| Respiratory | Clear to auscultation; no crackles or clubbing |
| Cardiovascular | Occasional ectopic beats; no murmur; no ankle swelling |
| Skin | No erythema nodosum, lupus pernio, plaques or scar infiltration |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-02-23 | FVC measured/predicted | 74 | % | >=80% | Low | S |
| 2026-02-23 | FEV1 measured/predicted | 76 | % | >=80% | Low | S |
| 2026-02-23 | FEV1/FVC | 80 | % | >=70% | Normal | S |
| 2026-02-23 | Diffusion capacity.carbon monoxide/Predicted | 62 | % | >=80% | Low | S |
| 2026-02-23 | Calcium [Mass/volume] in Serum or Plasma | 10.7 | mg/dL | 8.6-10.3 mg/dL | High | S |
| 2026-02-23 | Creatinine [Mass/volume] in Serum or Plasma | 1.04 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-02-23 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 65 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-02-23 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | | | S |
Assessment
- Pulmonary sarcoidosis with lymph node involvement (D86.2). Sarcoidosis is confirmed to the standard the ATS guideline asks: a compatible clinical and radiologic picture, non-necrotizing granulomas in lymph nodes obtained by EBUS rather than mediastinoscopy, and no evidence so far of tuberculosis, fungal infection or lymphoma, with final cultures to follow. The lavage lymphocytosis with a high CD4 to CD8 ratio supports it. It is Scadding stage II, with mild restriction and a reduced DLCO, and she is symptomatic. The granulomas reported at her abdominal operation are consistent with long-standing disease. Sarcoidosis is more common in Black women in the United States and carries a higher risk of severe and fatal disease, so a complete organ screen matters. Serum ACE adds nothing to the diagnosis and is not needed. [S]
- Hypercalcemia (E83.52). Granulomas convert vitamin D to its active form, as the high 1,25-dihydroxyvitamin D with a low 25-hydroxyvitamin D shows. The supplement made it worse. No calcium or vitamin D supplements until the calcium is normal on treatment; then vitamin D may be replaced cautiously with calcium checks. Bone protection on glucocorticoids should use a bisphosphonate, not calcium tablets. [S]
- Palpitations with first-degree atrioventricular block and ventricular ectopy (R00.2). Unexplained conduction disease and ventricular ectopy in a patient with proven extracardiac sarcoidosis means cardiac sarcoidosis must be excluded. The HRS consensus and the AHA statement advise Holter monitoring, an echocardiogram, cardiac MRI with late gadolinium enhancement and cardiac FDG-PET. The PET must be done before any glucocorticoid, which would mask active inflammation, and needs a 72-hour high-fat, very-low-carbohydrate preparation. [S]
Data reviewed: Dr. Fontenot's intake note and results. Chest radiograph: bilateral hilar adenopathy with upper-zone reticulonodular opacities (Scadding stage II). High-resolution CT: hilar, subcarinal and right paratracheal nodes up to 2.4 cm with fine calcification; perilymphatic micronodules in both upper lobes; no fibrosis. EBUS-guided aspiration of stations 4R, 7 and 11L: non-necrotizing granulomas; acid-fast and fungal stains negative; cultures pending; lavage lymphocytes 32 percent with a CD4 to CD8 ratio of 5.2. Interferon-gamma release assay and HIV negative. ECG: sinus rhythm, PR 240 ms, frequent unifocal ventricular ectopy. Pulmonary function today: FVC 74 percent, FEV1 76 percent, FEV1/FVC 80 percent, total lung capacity 78 percent, DLCO 62 percent of predicted. Calcium 10.7 mg/dL today off the supplement (10.8 at the first visit); creatinine 1.04 mg/dL; 25-hydroxyvitamin D 22 ng/mL; 1,25-dihydroxyvitamin D 84 pg/mL; alkaline phosphatase 128 U/L; lymphocytes 0.9; NT-proBNP 210 pg/mL. [S]
Plan of Treatment
- Complete the screen for other organ involvement: ophthalmology examination now and yearly; calcium, creatinine and liver tests at each visit; the ECG is done. [S]
- Cardiac evaluation within two weeks and before any treatment: 24-hour Holter, echocardiogram, cardiac MRI with late gadolinium enhancement, and cardiac FDG-PET with dietary preparation; joint review with cardiology. [S]
- If cardiac sarcoidosis is confirmed: prednisone 40 mg daily for about two months, then a slow taper over about six months toward 5 to 10 mg, with methotrexate 15 mg weekly rising to 20 mg and folic acid, continued for at least a year; if the heart is not involved, the same steroid-sparing approach for symptomatic stage II disease with impaired lung function, at a lower prednisone dose. [S]
- If cardiac sarcoidosis is confirmed with an ejection fraction above 35 percent, an electrophysiology study, and a dual-chamber defibrillator if sustained ventricular tachycardia is induced, given the conduction disease; a beta-blocker for the ventricular ectopy. [S]
- Before immunosuppression: hepatitis B and C serology (drawn today), tuberculosis already excluded by the interferon-gamma release assay, and PCV20, recombinant zoster and, if non-immune, hepatitis B vaccines; no live vaccines on treatment. [S]
- On treatment: pneumocystis prophylaxis with atovaquone while prednisone is 20 mg or more with methotrexate, avoiding trimethoprim-sulfamethoxazole; a bone density scan and a bisphosphonate; glucose, blood pressure, weight, sleep and mood checks; methotrexate blood tests every two to four weeks for three months, then every eight to twelve weeks; no alcohol. [S]
- Response assessment: lung function about two months after starting and then every three to six months; repeat cardiac FDG-PET three to six months into treatment. [S]
- Performing and travel: postpone concerts until the cardiac tests and any device implant are done, then resume a lighter schedule with rest days; voice care; carry a medicine list and any device card when travelling. [S]
- Discussed with Dr. Fontenot the same day and with cardiology. The diagnosis and the reasons for testing her heart before starting prednisone were explained to Ms. Jackson, who agreed to the plan and to postponing her concerts for now. She decides who else receives this note. [S]
- Follow-up: Holter tomorrow; echocardiogram, eye examination, cardiac MRI and FDG-PET within two weeks; joint review with Dr. Fontenot and cardiology in two weeks to decide treatment; pulmonology review with lung function about two months after treatment starts. [S]